In a collaboration with Istituto Superiore di Sanità and CNR, IRBM has published research that identified new molecules which block the transmission of the malaria parasite from an infected person to the mosquito, the first step in developing new drugs to eliminate this major infectious disease.
Our Chief Scientific Officer, Carlo Toniatti, has been featured in The Medicine Maker, where he explored how we can catalyse the discovery and development of oncology drugs.
In the article, he discusses how to overcome the challenges in developing efficacious cancer therapeutics through consultative collaboration between academia and industry. Moreover, he talks about the current reproducibility crisis impacting the entire biosciences ecosystem, calling for a cultural shift in how success is perceived in research and development.
Read the article in full here: https://themedicinemaker.com/discovery-development/putting-patients-first